Inozyme Pharma Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	2016 - 2020
Cash & Equivalents	154.74	141.58	275.24	231.93	193.32	139.5	Upgrade
Accounts Receivable	203.27	183.41	168.9	136.21	150.69	198.14	Upgrade
Other Receivables	33.52	33.46	34.13	6.73	8.81	5.16	Upgrade
Inventory	88.97	88.38	90.77	94.62	79.73	59.25	Upgrade
Prepaid Expenses	-	-	-	6.72	0.16	0.99	Upgrade
Loans Receivable Current	-	-	-	-	1.1	1.04	Upgrade
Other Current Assets	46.69	72.18	69.02	128.44	167.13	180.13	Upgrade
Total Current Assets	527.19	519.01	638.05	604.65	600.93	584.2	Upgrade
Property, Plant & Equipment	936.14	941.6	921.71	856.32	878.99	852.57	Upgrade
Goodwill	179.58	179.58	231.52	354.23	354.23	354.23	Upgrade
Other Intangible Assets	72.29	72.84	64.8	54.14	48.17	49.25	Upgrade
Long-Term Investments	68.77	73.83	74.06	114.47	118.01	106.04	Upgrade
Long-Term Deferred Tax Assets	26.28	25.97	19.41	14.34	12.8	11.32	Upgrade
Long-Term Deferred Charges	46.55	48.4	44.63	40.31	26.5	13.81	Upgrade
Other Long-Term Assets	93.86	96.23	100.96	145.81	122.43	130.51	Upgrade
Total Assets	1,951	1,957	2,095	2,184	2,162	2,102	Upgrade
Accounts Payable	161.2	157.78	151.77	196.12	118.62	130.93	Upgrade
Accrued Expenses	3.29	10.94	9.89	12.57	23.1	16.06	Upgrade
Short-Term Debt	154.36	154.54	251.56	231.67	432.05	535.44	Upgrade
Current Portion of Long-Term Debt	200.29	241.16	155.71	29	-	30	Upgrade
Current Unearned Revenue	217.66	216.91	205.65	169.92	139.39	122.02	Upgrade
Current Portion of Leases	-	0.79	0.7	-	-	-	Upgrade
Current Income Taxes Payable	12.73	9.72	14.84	15.03	13.6	13.62	Upgrade
Other Current Liabilities	45.77	51.1	32.82	34.37	39.64	36.67	Upgrade
Total Current Liabilities	795.29	842.94	822.94	688.67	766.41	884.74	Upgrade
Long-Term Debt	189.13	151.37	305.99	301.95	214.44	84.13	Upgrade
Long-Term Leases	2.54	2.36	2.81	1.55	41.61	77.48	Upgrade
Long-Term Unearned Revenue	3.38	3.38	-	-	-	-	Upgrade
Long-Term Deferred Tax Liabilities	5.72	5.85	7.01	6.38	5.36	5.48	Upgrade
Other Long-Term Liabilities	17.89	17.89	17.89	29.98	31.2	0.2	Upgrade
Total Liabilities	1,014	1,024	1,157	1,029	1,059	1,052	Upgrade
Common Stock	358.63	358.63	358.63	358.63	358.63	358.63	Upgrade
Additional Paid-In Capital	646.31	646.31	649.37	660.81	660.81	660.81	Upgrade
Retained Earnings	-138.07	-141.41	-160.46	80.87	32.63	-17.87	Upgrade
Treasury Stock	-17	-17	-	-	-	-	Upgrade
Comprehensive Income & Other	2.2	2.26	0.14	1.09	0	0.5	Upgrade
Total Common Equity	852.08	848.79	847.68	1,101	1,052	1,002	Upgrade
Minority Interest	84.62	84.87	90.83	54.36	50.95	47.83	Upgrade
Shareholders' Equity	936.69	933.66	938.51	1,156	1,103	1,050	Upgrade
Total Liabilities & Equity	1,951	1,957	2,095	2,184	2,162	2,102	Upgrade
Total Debt	546.32	550.22	716.76	564.16	688.11	727.04	Upgrade
Net Cash (Debt)	-391.58	-408.64	-441.52	-332.23	-494.79	-587.55	Upgrade
Net Cash Per Share	-1.08	-1.14	-1.23	-0.93	-1.38	-1.63	Upgrade
Filing Date Shares Outstanding	355.4	355.4	358.63	358.63	358.63	358.63	Upgrade
Total Common Shares Outstanding	355.4	355.4	358.63	358.63	358.63	358.63	Upgrade
Working Capital	-268.1	-323.93	-184.89	-84.02	-165.48	-300.54	Upgrade
Book Value Per Share	2.40	2.39	2.36	3.07	2.93	2.79	Upgrade
Tangible Book Value	600.21	596.38	551.36	693.03	649.67	598.6	Upgrade
Tangible Book Value Per Share	1.69	1.68	1.54	1.93	1.81	1.67	Upgrade
Buildings	-	173.16	164.57	139.67	137.79	127.48	Upgrade
Machinery	-	1,179	1,085	666.48	1,043	955.74	Upgrade
Construction In Progress	-	90.51	109.35	118.21	89.58	108.22	Upgrade

Source: S&P Global Market Intelligence. Utility template. Financial Sources.